Lopez AT - Search Results

1

Treatment Outcomes of Immune-Related Cutaneous Adverse Events.

Phillips GS, Wu J, Hellmann MD, Postow MA, Rizvi NA, Freites-Martinez A, Chan D, Dusza S, Motzer RJ, Rosenberg JE, Callahan MK, Chapman PB, Geskin L, Lopez AT, Reed VA, Fabbrocini G, Annunziata MC, Kukoyi O, Pabani A, Yang CH, Chung WH, Markova A, Lacouture ME. Phillips GS, et al. Among authors: lopez at. J Clin Oncol. 2019 Oct 20;37(30):2746-2758. doi: 10.1200/JCO.18.02141. Epub 2019 Jun 19. J Clin Oncol. 2019. PMID: 31216228 Free PMC article.

2

Immunophenotypic CD56 Variation Within a Single Patient With Blastic Plasmacytoid Dendritic Cell Neoplasm.

Lopez AT, Shaw KS, Yamany T, Husain S, Geskin L. Lopez AT, et al. JAMA Dermatol. 2018 Apr 1;154(4):492-494. doi: 10.1001/jamadermatol.2017.6061. JAMA Dermatol. 2018. PMID: 29490374 No abstract available.

3

A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors.

Lopez AT, Khanna T, Antonov N, Audrey-Bayan C, Geskin L. Lopez AT, et al. Int J Dermatol. 2018 Jun;57(6):664-669. doi: 10.1111/ijd.13984. Epub 2018 Apr 6. Int J Dermatol. 2018. PMID: 29630716 Review.

4

Secondary Prevention Strategies for Nonmelanoma Skin Cancer.

Lopez AT, Carvajal RD, Geskin L. Lopez AT, et al. Oncology (Williston Park). 2018 Apr 15;32(4):195-200. Oncology (Williston Park). 2018. PMID: 29684233 Free article. Review.

5

Nevus anemicus: An island of sparing in the setting of drug-induced hypersensitivity.

Lopez AT, Rotemberg V, Husain S, Schneiderman P, Geskin L. Lopez AT, et al. JAAD Case Rep. 2018 Jun 28;4(6):615-617. doi: 10.1016/j.jdcr.2018.03.012. eCollection 2018 Jul. JAAD Case Rep. 2018. PMID: 30003132 Free PMC article. No abstract available.

6

A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.

Lopez AT, Geskin L. Lopez AT, et al. Oncologist. 2018 Oct;23(10):1119-1126. doi: 10.1634/theoncologist.2018-0128. Epub 2018 Jul 17. Oncologist. 2018. PMID: 30018132 Free PMC article. Review.

7

Programmed cell death protein-1 inhibitor-induced granuloma annulare and hypertrophic lichen planus masquerading as squamous cell carcinoma.

Fontecilla NM, Kittler NW, Lopez A, Yang C, Geskin L. Fontecilla NM, et al. JAAD Case Rep. 2018 Jul 24;4(7):636-639. doi: 10.1016/j.jdcr.2018.01.020. eCollection 2018 Aug. JAAD Case Rep. 2018. PMID: 30094305 Free PMC article. No abstract available.

8

The Role of Oncolytic Viruses in the Treatment of Melanoma.

Bayan CY, Lopez AT, Gartrell RD, Komatsubara KM, Bogardus M, Rao N, Chen C, Hart TD, Enzler T, Rizk EM, Pradhan JS, Marks DK, Geskin LJ, Saenger YM. Bayan CY, et al. Among authors: lopez at. Curr Oncol Rep. 2018 Aug 25;20(10):80. doi: 10.1007/s11912-018-0729-3. Curr Oncol Rep. 2018. PMID: 30145781 Free PMC article. Review.

9

Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma.

Lopez AT, Bates S, Geskin L. Lopez AT, et al. Am J Clin Dermatol. 2018 Dec;19(6):805-819. doi: 10.1007/s40257-018-0380-7. Am J Clin Dermatol. 2018. PMID: 30173294 Review.

10

Successful treatment of drug reaction with eosinophilia and systemic symptoms syndrome relapse with oral pulsed dexamethasone.

Bayan CY, Lopez A, Fontecilla NM, Geskin LJ. Bayan CY, et al. JAAD Case Rep. 2018 Oct 13;4(9):959-961. doi: 10.1016/j.jdcr.2018.07.015. eCollection 2018 Oct. JAAD Case Rep. 2018. PMID: 30364766 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page